Differential expression of chemokines in inflammatory myopathies

Neurology

Volumn 58, Issue 12, 2002, Pages 1779-1785

  De Bleecker, Jan L ^a   De Paepe, Boel ^a   Vanwalleghem, Iris E ^a   Michael Schroder J ^b  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; MONOCYTE CHEMOTACTIC PROTEIN 3; RANTES; THYMUS AND ACTIVATION REGULATED CHEMOKINE;

ARTICLE; DERMATOMYOSITIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; INFLAMMATORY CELL; MACROPHAGE; MEMORY CELL; MYOPATHY; POLYMYOSITIS; PRIORITY JOURNAL;

EID: 0037172893     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.58.12.1779     Document Type: Article

References (50)

1. Dancing to the tune of chemokines
2. Chemokines: Chemotactic cytokines that mediate inflammation
3. Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s
4. Polymyositis, dermatomyositis, and inclusion body myositis
5. Evaluation and treatment of the idiopathic inflammatory myopathies
6. Monoclonal antibody analysis of mononuclear cells in myopathies. I: Quantitation of subsets according to diagnosis and sites of accumulation and demonstration and counts of muscle fibers invaded by T cells
7. Monoclonal antibody analysis of mononuclear cells in myopathies. V: Identification and quantitation of T8+ cytotoxic and T8+ suppressor cells
8. Immunocytochemical study of CD45 T cell isoforms in inflammatory myopathies
9. Mononuclear cells in myopathies: Quantitation of functionally distinct subsets, recognition of antigenspecific cell-mediated cytotoxicity in some diseases, and implications for the pathogenesis of the different inflammatory myopathies
10. Microvascular changes in early and advanced dermatomyositis: A quantitative study
11. The role of cytotoxic effector molecules and cytokines in inflammatory myopathies
12. Expression of cell adhesion molecules in inflammatory myopathies and Duchenne dystrophy
13. Expression of cell adhesion molecules in inflammatory myopathies
14. Immunolocalization of tumor necrosis factor-alpha and its receptors in inflammatory myopathies
15. Tumor necrosis factor-alpha expression in muscles of polymyositis and dermatomyositis
16. Signal transducer and activator of transcription 1 in human muscle implications in inflammatory myopathies
17. Major histocompatibility complex class I antigen expression, immunolocalization of interferon subtypes, and T cell-mediated cytotoxicity in myopathies
18. Analysis of cytokine expression in muscle in inflammatory myopathies, Duchenne dystrophy, and non-weak controls
19. Cytokine expression profile in idiopathic inflammatory myopathies
20. Inclusion body myositis
21. The polymyositis and dermatomyositis syndromes
22. High expression of the CC chemokine TARC in Reed-Sternberg cells: A possible explanation for the characteristic T-cell infiltrate in Hodgkin's lymphoma
23. Elevated expression of the CC chemokines regulated on activation, normal T cell expressed and secreted (RANTES) in advanced breast carcinoma
24. Inflammatory myopathies and systemic disorders: A review of immunopathogenetic mechanisms and clinical features
25. Cellular immune mechanisms in inflammatory myopathies
26. Lymphocyte homing and homeostasis
27. Peripheral lymphoid tissue-like adhesion molecule expression in nodular infiltrates in inflammatory myopathies
28. MHC class I, MHC class II and intercellular adhesion molecule-1 (ICAM-1) expression in inflammatory myopathies
29. T-cell infiltration in polymyositis is characterized by coexpression of cytotoxic and T-cell activating cytokine transcripts
30. Interleukin(IL)-lbeta and IL-lbeta mRNA expression in normal and diseased skeletal muscle assessed by immunocytochemistry, immunoblotting and reverse transcriptase-nested polymerase chain reaction
31. New developments in the role of cytokines and chemokines in inflammatory myopathies
32. Regulatory roles of tumor necrosis factor-alpha and interleukin-1beta in monocyte chemoattractant protein-1 mediated pulmonary granuloma formation in the rat
33. Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTES
34. Microvascular deposition of complement membrane attack complex in dermatomyositis
35. Local expression of monocyte chemoattractant protein-1 (MCP-1) in idiopathic inflammatory myopathies
36. Increased expression of beta-chemokines in muscle of patients with inflammatory myopathies
37. Expression of monocyte chemoattractant protein-1 and other b-chemokines by resident glia and inflammatory cells in multiple sclerosis lesions
38. The chemoattractant activity of rheumatoid synovial fluid for human lymphocytes is due to multiple cytokines
39. Monocyte-chemoattractant protein 1 gene expression in intestinal epithelial cells and inflammatory bowel disease mucosa
40. MCP-1 mRNA expression in basal keratinocytes of psoriatic lesions
41. Differential and sequential expression of multiple chemokines during elicitation of allergic contact hypersensitivity
42. Chemokines IL-8, GROalpha, MCP-1, IP-10, and Mig are sequentially and differentially expressed during phase-specific infiltration of leukocyte subsets in human wound healing
43. Monocyte chemoattractant protein-1 and RANTES are chemotactic for graft infiltrating lymphocytes during acute lung allograft rejection
44. Sublytic concentrations of the membrane attack complex of complement induce endothelial interleukin-8 and monocyte chemoattractant protein-1 through nuclear factor-κB activation
45. The membrane attack complex of complement induces interleukin-8 and monocyte chemoattractant protein-1 secretion from human umbilical vein endothelial cells
46. Interaction of IgA with Fc alpha receptors of human mesangial cells activates transcription factor nuclear factor-κB and induces expression and synthesis of monocyte chemoattractant protein-1, IL-8, and IFN-inducible protein 10
47. Enhancement by the complement membrane attack complex of tumor necrosis factor-alpha-induced endothelial cell expression of E-selectin and ICAM-1
48. Chemokine expression and leucocyte infiltration in Sjögren's syndrome
49. Some aspects of IL-8 pathophysiology III: Chemokine interaction with endothelial cells